Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 324

1.

RGS9-2 rescues dopamine D2 receptor levels and signaling in DYT1 dystonia mouse models.

Bonsi P, Ponterio G, Vanni V, Tassone A, Sciamanna G, Migliarini S, Martella G, Meringolo M, Dehay B, Doudnikoff E, Zachariou V, Goodchild RE, Mercuri NB, D'Amelio M, Pasqualetti M, Bezard E, Pisani A.

EMBO Mol Med. 2018 Dec 14. pii: e9283. doi: 10.15252/emmm.201809283. [Epub ahead of print]

2.

Transcranial magnetic stimulation predicts cognitive decline in patients with Alzheimer's disease.

Motta C, Di Lorenzo F, Ponzo V, Pellicciari MC, Bonnì S, Picazio S, Mercuri NB, Caltagirone C, Martorana A, Koch G.

J Neurol Neurosurg Psychiatry. 2018 Dec;89(12):1237-1242. doi: 10.1136/jnnp-2017-317879. Epub 2018 Jul 21.

PMID:
30464028
3.

Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study.

Alessandrini M, Liguori C, Viziano A, Izzi F, Capoccia D, Lanzillotta A, Placidi F, Mercuri NB, Micarelli A.

Sleep Breath. 2018 Nov 19. doi: 10.1007/s11325-018-1754-z. [Epub ahead of print]

PMID:
30456739
4.

Electrophysiological Characterization of Novel Effects of the Uptake-2 Blocker Decynium-22 (D-22) on Dopaminergic Neurons in the Substantia Nigra Pars Compacta.

Lloyd JT, Martini A, McDouall A, Sood R, Freestone PS, Mercuri NB, Lipski J.

Neuroscience. 2018 Nov 14;396:154-165. doi: 10.1016/j.neuroscience.2018.11.005. [Epub ahead of print]

PMID:
30447392
5.

Pisa Syndrome in Parkinson's Disease: Evidence for Bilateral Vestibulospinal Dysfunction.

Di Lazzaro G, Schirinzi T, Giambrone MP, Di Mauro R, Palmieri MG, Rocchi C, Tinazzi M, Mercuri NB, Di Girolamo S, Pisani A.

Parkinsons Dis. 2018 Oct 15;2018:8673486. doi: 10.1155/2018/8673486. eCollection 2018.

6.

Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms.

Liguori C, Mercuri NB, Nuccetelli M, Izzi F, Bernardini S, Placidi F.

J Alzheimers Dis. 2018;66(3):993-999. doi: 10.3233/JAD-180769.

PMID:
30372684
7.

Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study.

Rocchi C, Placidi F, Liguori C, Del Bianco C, Lauretti B, Diomedi M, Pisani A, Mercuri NB, Izzi F.

Sleep Med. 2018 Dec;52:163-167. doi: 10.1016/j.sleep.2018.08.023. Epub 2018 Sep 17.

PMID:
30359891
8.

LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer's disease patients.

Di Lorenzo F, Motta C, Bonnì S, Mercuri NB, Caltagirone C, Martorana A, Koch G.

Brain Stimul. 2018 Oct 19. pii: S1935-861X(18)30355-3. doi: 10.1016/j.brs.2018.10.009. [Epub ahead of print]

PMID:
30352737
9.

CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients.

Schirinzi T, Sancesario GM, Di Lazzaro G, Biticchi B, Colona VL, Mercuri NB, Bernardini S, Pisani A.

Parkinsonism Relat Disord. 2018 Oct 15. pii: S1353-8020(18)30452-8. doi: 10.1016/j.parkreldis.2018.10.018. [Epub ahead of print]

PMID:
30348495
10.

Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis.

Liguori C, Ferini-Strambi L, Izzi F, Mari L, Manfredi N, D'Elia A, Mercuri NB, Placidi F.

Br J Clin Pharmacol. 2018 Oct 16. doi: 10.1111/bcp.13772. [Epub ahead of print]

PMID:
30328132
11.

mGluR1-Dependent Long Term Depression in Rodent Midbrain Dopamine Neurons Is Regulated by Neuregulin 1/ErbB Signaling.

Ledonne A, Mercuri NB.

Front Mol Neurosci. 2018 Oct 1;11:346. doi: 10.3389/fnmol.2018.00346. eCollection 2018.

12.

Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology.

Costa C, Romoli M, Liguori C, Farotti L, Eusebi P, Bedetti C, Siliquini S, Cesarini EN, Romigi A, Mercuri NB, Parnetti L, Calabresi P.

Neurobiol Aging. 2019 Jan;73:61-67. doi: 10.1016/j.neurobiolaging.2018.09.006. Epub 2018 Sep 18.

PMID:
30317034
13.

In vivo mapping of brainstem nuclei functional connectivity disruption in Alzheimer's disease.

Serra L, D'Amelio M, Di Domenico C, Dipasquale O, Marra C, Mercuri NB, Caltagirone C, Cercignani M, Bozzali M.

Neurobiol Aging. 2018 Dec;72:72-82. doi: 10.1016/j.neurobiolaging.2018.08.012. Epub 2018 Aug 23.

14.

Tissue degeneration in ALS affected spinal cord evaluated by Raman spectroscopy.

Picardi G, Spalloni A, Generosi A, Paci B, Mercuri NB, Luce M, Longone P, Cricenti A.

Sci Rep. 2018 Aug 30;8(1):13110. doi: 10.1038/s41598-018-31469-4.

15.

From Traumatic Childhood to Cocaine Abuse: The Critical Function of the Immune System.

Lo Iacono L, Catale C, Martini A, Valzania A, Viscomi MT, Chiurchiù V, Guatteo E, Bussone S, Perrone F, Di Sabato P, Aricò E, D'Argenio A, Troisi A, Mercuri NB, Maccarrone M, Puglisi-Allegra S, Casella P, Carola V.

Biol Psychiatry. 2018 Dec 15;84(12):905-916. doi: 10.1016/j.biopsych.2018.05.022. Epub 2018 Jun 11.

PMID:
30029767
16.

Safinamide effect on sleep disturbances and daytime sleepiness in motor fluctuating Parkinson's disease patients: A validated questionnaires-controlled study.

Liguori C, Stefani A, Ruffini R, Mercuri NB, Pierantozzi M.

Parkinsonism Relat Disord. 2018 Jun 30. pii: S1353-8020(18)30301-8. doi: 10.1016/j.parkreldis.2018.06.033. [Epub ahead of print] No abstract available.

PMID:
30006034
17.

Proteomics and Toxicity Analysis of Spinal-Cord Primary Cultures upon Hydrogen Sulfide Treatment.

Greco V, Spalloni A, Corasolla Carregari V, Pieroni L, Persichilli S, Mercuri NB, Urbani A, Longone P.

Antioxidants (Basel). 2018 Jul 10;7(7). pii: E87. doi: 10.3390/antiox7070087.

18.

Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine.

Liguori C, Izzi F, Manfredi N, Mercuri NB, Placidi F.

Epilepsy Behav Case Rep. 2018 Mar 12;10:35-37. doi: 10.1016/j.ebcr.2018.02.004. eCollection 2018.

19.

Clinical value of CSF amyloid-beta-42 and tau proteins in Progressive Supranuclear Palsy.

Schirinzi T, Sancesario GM, Di Lazzaro G, Scalise S, Colona VL, Imbriani P, Mercuri NB, Bernardini S, Lang AE, Pisani A.

J Neural Transm (Vienna). 2018 Sep;125(9):1373-1379. doi: 10.1007/s00702-018-1893-1. Epub 2018 Jun 14.

PMID:
29948175
20.

Reversal of dopamine-mediated firing inhibition through activation of the dopamine transporter in substantia nigra pars compacta neurons.

Aversa D, Martini A, Guatteo E, Pisani A, Mercuri NB, Berretta N.

Br J Pharmacol. 2018 Sep;175(17):3534-3547. doi: 10.1111/bph.14422. Epub 2018 Jul 23.

PMID:
29933497
21.

Amyloid-Mediated Cholinergic Dysfunction in Motor Impairment Related to Alzheimer's Disease.

Schirinzi T, Di Lorenzo F, Sancesario GM, Di Lazzaro G, Ponzo V, Pisani A, Mercuri NB, Koch G, Martorana A.

J Alzheimers Dis. 2018;64(2):525-532. doi: 10.3233/JAD-171166.

PMID:
29914023
22.

Comments on: "Complementary and alternative therapies for restless legs syndrome: An evidence-based systematic review".

Alwardat M, Schirinzi T, Di Lazzaro G, Mercuri NB, Pisani A.

Sleep Med Rev. 2018 Aug;40:215-216. doi: 10.1016/j.smrv.2018.05.002. Epub 2018 May 12. No abstract available.

PMID:
29887255
23.

Continuous Positive Airway Pressure Treatment May Improve Optic Nerve Function in Obstructive Sleep Apnea: An Electrophysiological Study.

Liguori C, Placidi F, Palmieri MG, Izzi F, Ludovisi R, Mercuri NB, Pierantozzi M.

J Clin Sleep Med. 2018 Jun 15;14(6):953-958. doi: 10.5664/jcsm.7158.

24.

Dopamine loss alters the hippocampus-nucleus accumbens synaptic transmission in the Tg2576 mouse model of Alzheimer's disease.

Cordella A, Krashia P, Nobili A, Pignataro A, La Barbera L, Viscomi MT, Valzania A, Keller F, Ammassari-Teule M, Mercuri NB, Berretta N, D'Amelio M.

Neurobiol Dis. 2018 Aug;116:142-154. doi: 10.1016/j.nbd.2018.05.006. Epub 2018 May 17.

PMID:
29778899
25.

Dystonia as a network disorder: a concept in evolution.

Schirinzi T, Sciamanna G, Mercuri NB, Pisani A.

Curr Opin Neurol. 2018 Aug;31(4):498-503. doi: 10.1097/WCO.0000000000000580.

PMID:
29746398
26.

Does Pisa syndrome affect upper limb function in patients with Parkinson's disease? An observational cross-sectional study.

Alwardat M, Di Lazzaro G, Schirinzi T, Sinibaldi Salime P, Mercuri NB, Pisani A.

NeuroRehabilitation. 2018;42(2):143-148. doi: 10.3233/NRE-172274.

PMID:
29562562
27.

Centrality of Early Synaptopathy in Parkinson's Disease.

Imbriani P, Schirinzi T, Meringolo M, Mercuri NB, Pisani A.

Front Neurol. 2018 Mar 1;9:103. doi: 10.3389/fneur.2018.00103. eCollection 2018. Review.

28.

When Cognitive Decline and Depression Coexist in the Elderly: CSF Biomarkers Analysis Can Differentiate Alzheimer's Disease from Late-Life Depression.

Liguori C, Pierantozzi M, Chiaravalloti A, Sancesario GM, Mercuri NB, Franchini F, Schillaci O, Sancesario G.

Front Aging Neurosci. 2018 Feb 23;10:38. doi: 10.3389/fnagi.2018.00038. eCollection 2018.

29.

miR-34b/c Regulates Wnt1 and Enhances Mesencephalic Dopaminergic Neuron Differentiation.

De Gregorio R, Pulcrano S, De Sanctis C, Volpicelli F, Guatteo E, von Oerthel L, Latagliata EC, Esposito R, Piscitelli RM, Perrone-Capano C, Costa V, Greco D, Puglisi-Allegra S, Smidt MP, di Porzio U, Caiazzo M, Mercuri NB, Li M, Bellenchi GC.

Stem Cell Reports. 2018 Apr 10;10(4):1237-1250. doi: 10.1016/j.stemcr.2018.02.006. Epub 2018 Mar 8.

30.

3,4-Methylenedioxymethamphetamine (MDMA) Alters Synaptic Dopamine Release in the Dorsal Striatum Through Nicotinic Receptors and DAT Inhibition.

Rizzo FR, Federici M, Mercuri NB.

Neuroscience. 2018 May 1;377:69-76. doi: 10.1016/j.neuroscience.2018.02.037. Epub 2018 Mar 3.

PMID:
29510210
31.

Early structural and functional plasticity alterations in a susceptibility period of DYT1 dystonia mouse striatum.

Maltese M, Stanic J, Tassone A, Sciamanna G, Ponterio G, Vanni V, Martella G, Imbriani P, Bonsi P, Mercuri NB, Gardoni F, Pisani A.

Elife. 2018 Mar 5;7. pii: e33331. doi: 10.7554/eLife.33331.

32.

Ambra1 Shapes Hippocampal Inhibition/Excitation Balance: Role in Neurodevelopmental Disorders.

Nobili A, Krashia P, Cordella A, La Barbera L, Dell'Acqua MC, Caruso A, Pignataro A, Marino R, Sciarra F, Biamonte F, Scattoni ML, Ammassari-Teule M, Cecconi F, Berretta N, Keller F, Mercuri NB, D'Amelio M.

Mol Neurobiol. 2018 Oct;55(10):7921-7940. doi: 10.1007/s12035-018-0911-5. Epub 2018 Feb 27.

33.

Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea?

Izzi F, Placidi F, Liguori C, Lauretti B, Marfia GA, Pisani A, Mercuri NB, Rocchi C.

Sleep Med. 2018 Feb;42:68-72. doi: 10.1016/j.sleep.2017.09.029. Epub 2017 Oct 23.

PMID:
29458748
34.

Neuregulin 1/ErbB signalling modulates hippocampal mGluRI-dependent LTD and object recognition memory.

Ledonne A, Mango D, Latagliata EC, Chiacchierini G, Nobili A, Nisticò R, D'Amelio M, Puglisi-Allegra S, Mercuri NB.

Pharmacol Res. 2018 Apr;130:12-24. doi: 10.1016/j.phrs.2018.02.003. Epub 2018 Feb 7.

PMID:
29427771
35.

Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.

Liguori C, Izzi F, Manfredi N, D'Elia A, Mari L, Mercuri NB, Fabio P.

Epilepsy Behav. 2018 Mar;80:173-176. doi: 10.1016/j.yebeh.2018.01.001. Epub 2018 Feb 3.

PMID:
29414548
36.

Lacosamide in the Management of Behavioral Symptoms in Frontotemporal Dementia: A 2-Case Report.

Di Lorenzo F, Motta C, Caltagirone C, Koch G, Mercuri NB, Martorana A.

Alzheimer Dis Assoc Disord. 2018 Oct-Dec;32(4):364-365. doi: 10.1097/WAD.0000000000000245. No abstract available.

PMID:
29389672
37.

Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.

Liguori C, Mercuri NB, Stefani A, Pierantozzi M.

Sleep Med. 2018 Jan;41:113-114. doi: 10.1016/j.sleep.2017.09.017. No abstract available.

PMID:
29268951
38.

Cerebral blood volume lesion extent predicts functional outcome in patients with vertebral and basilar artery occlusion.

Alemseged F, Shah DG, Bivard A, Kleinig TJ, Yassi N, Diomedi M, Di Giuliano F, Sharma G, Drew R, Yan B, Dowling RJ, Bush S, Sallustio F, Caltagirone C, Mercuri NB, Floris R, Parsons MW, Levi CR, Mitchell PJ, Davis SM, Campbell BC.

Int J Stroke. 2017 Jan 1:1747493017744465. doi: 10.1177/1747493017744465. [Epub ahead of print]

PMID:
29160168
39.

Enhanced mu opioid receptor-dependent opioidergic modulation of striatal cholinergic transmission in DYT1 dystonia.

Ponterio G, Tassone A, Sciamanna G, Vanni V, Meringolo M, Santoro M, Mercuri NB, Bonsi P, Pisani A.

Mov Disord. 2018 Feb;33(2):310-320. doi: 10.1002/mds.27212. Epub 2017 Nov 18.

PMID:
29150865
40.

Abnormal cervical lymph nodes in multiple sclerosis: a preliminary ultrasound study.

Di Giuliano F, Albanese M, Picchi E, Mori F, Buttari F, Marfia GA, Garaci F, Mercuri NB, Floris R, Centonze D, Marziali S.

Radiol Med. 2018 Mar;123(3):202-208. doi: 10.1007/s11547-017-0829-4. Epub 2017 Nov 7.

PMID:
29116601
41.

Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology.

Liguori C, Chiaravalloti A, Izzi F, Nuccetelli M, Bernardini S, Schillaci O, Mercuri NB, Placidi F.

Brain. 2017 Dec 1;140(12):e75. doi: 10.1093/brain/awx281. No abstract available.

PMID:
29077794
42.

Letter re: Prolonged sleep duration as a marker of early neurodegeneration predicting incident dementia.

Liguori C, Izzi F, Mercuri NB, Placidi F.

Neurology. 2017 Oct 3;89(14):1532. doi: 10.1212/WNL.0000000000004551. No abstract available.

PMID:
28972108
43.

Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.

Liguori C, Chiaravalloti A, Nuccetelli M, Izzi F, Sancesario G, Cimini A, Bernardini S, Schillaci O, Mercuri NB, Fabio P.

J Neurol. 2017 Nov;264(11):2215-2223. doi: 10.1007/s00415-017-8613-x. Epub 2017 Sep 12.

PMID:
28900724
44.

Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer's disease.

Schirinzi T, Di Lazzaro G, Sancesario GM, Colona VL, Scaricamazza E, Mercuri NB, Martorana A, Sancesario G.

J Neural Transm (Vienna). 2017 Dec;124(12):1621-1625. doi: 10.1007/s00702-017-1786-8. Epub 2017 Sep 2.

PMID:
28866757
45.

Commentary: Sleep Changes without Medial Temporal Lobe or Brain Cortical Changes in Community-Dwelling Individuals with Subjective Cognitive Decline.

Liguori C, Izzi F, Mercuri NB, Placidi F.

Front Neurol. 2017 Jun 9;8:262. doi: 10.3389/fneur.2017.00262. eCollection 2017. No abstract available.

46.

Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies.

Gaziev J, Marziali S, Paciaroni K, Isgrò A, Di Giuliano F, Rossi G, Marziali M, De Angelis G, Alfieri C, Ribersani M, Andreani M, Palmieri MG, Placidi F, Romigi A, Izzi F, Floris R, Mercuri NB.

Biol Blood Marrow Transplant. 2017 Sep;23(9):1531-1540. doi: 10.1016/j.bbmt.2017.05.033. Epub 2017 Jul 3.

47.

Facial diplegia resembling bilateral Ramsay Hunt Syndrome.

Marziali S, Picchi E, Di Giuliano F, Pisani A, Mercuri NB, Floris R, Albanese M.

J Neurol Sci. 2017 May 15;376:109-111. doi: 10.1016/j.jns.2017.03.011. Epub 2017 Mar 9. No abstract available.

PMID:
28431592
48.

Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments.

Liguori C, Piccirilli E, Izzi F, Mercuri NB, Tarantino U, Placidi F.

Eur Respir J. 2017 Apr 12;49(4). pii: 1602471. doi: 10.1183/13993003.02471-2016. Print 2017 Apr. No abstract available.

49.

Dopamine neuronal loss contributes to memory and reward dysfunction in a model of Alzheimer's disease.

Nobili A, Latagliata EC, Viscomi MT, Cavallucci V, Cutuli D, Giacovazzo G, Krashia P, Rizzo FR, Marino R, Federici M, De Bartolo P, Aversa D, Dell'Acqua MC, Cordella A, Sancandi M, Keller F, Petrosini L, Puglisi-Allegra S, Mercuri NB, Coccurello R, Berretta N, D'Amelio M.

Nat Commun. 2017 Apr 3;8:14727. doi: 10.1038/ncomms14727.

50.

Intermittent Short Sleep May Contribute to Orexinergic Signaling Dysregulation in Alzheimer's Disease.

Liguori C, Izzi F, Mercuri NB, Placidi F.

Sleep. 2017 Jan 1;40(1). doi: 10.1093/sleep/zsw027. No abstract available.

PMID:
28364471

Supplemental Content

Loading ...
Support Center